Neogi Tuhina
Boston University School of Medicine and School of Public Health, Boston, USA.
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 107(5):75-78. Epub 2017 Sep 29.
Osteoarthritis (OA) is the most common form of arthritis, with knee OA itself being among the most common conditions and a leading cause of disability among older adults worldwide. Pain is a key symptom in the decision to seek medical attention, yet available therapies for managing OA are limited with only minimal or moderate efficacy. Current approaches to pain management in OA have been rather non-specific, limited to acetaminophen or NSAIDs primarily, without targeting underlying structural lesions that may be contributing to pain in OA. With the advent of MRI, a number of studies have noted the importance of bone marrow lesions and synovitis/effusion to the pain experience in OA. These pathologic features are therefore attractive treatment targets, with some proof-of-concept studies demonstrating the potential efficacy of targeting these lesions. Another increasingly recognised important contribution to pain in OA is sensitisation, which is associated with pain severity. Synovitis/effusion have been identified as potentially leading to development and worsening of sensitisation. Much work remains to be done in understanding the mechanisms by which structural pathology causes pain; such insights are urgently needed to develop new treatment approaches to help millions of people worldwide who are burdened by pain from OA.
骨关节炎(OA)是最常见的关节炎形式,其中膝关节OA本身就是最常见的病症之一,也是全球老年人残疾的主要原因。疼痛是促使患者寻求医疗关注的关键症状,但现有的OA治疗方法有限,疗效仅为轻微或中度。目前OA疼痛管理方法相当缺乏针对性,主要限于对乙酰氨基酚或非甾体抗炎药,并未针对可能导致OA疼痛的潜在结构病变。随着磁共振成像(MRI)的出现,多项研究指出骨髓病变和滑膜炎/关节积液对OA疼痛体验的重要性。因此,这些病理特征是有吸引力的治疗靶点,一些概念验证研究证明了针对这些病变的潜在疗效。另一个在OA疼痛中日益被认识到的重要因素是敏化作用,它与疼痛严重程度相关。滑膜炎/关节积液已被确定为可能导致敏化作用的发展和恶化。在理解结构病理学导致疼痛的机制方面仍有许多工作要做;迫切需要这些见解来开发新的治疗方法,以帮助全球数百万受OA疼痛困扰的人。